I have more ‘on’ time
than I did with my
previous medicine.”
Individual results may vary.
RYTARY is superior to IR CD/LD (sometimes called Sinemet®)
in reducing many motor symptoms of Parkinson’s disease*
People who switched from IR CD/LD to RYTARY experienced:
- After switching to RYTARY, people had significantly less “off” time than they did when
taking IR CD/LD
- Percentage of “off” time at study start and study end: 36.9% and 23.8% with RYTARY vs 36.0% and 29.8% with IR CD/LD†
- After switching to RYTARY, people had significantly more “on” time without troublesome
dyskinesia than they did when taking IR CD/LD
- 1.8 hours with RYTARY vs 0.8 hours with IR CD/LD§
- After switching to RYTARY, people also experienced a significant improvement in motor functions, which can help when performing daily activities
- A different analysis of the same study found that optimized RYTARY provided more hours per
dose of “on” time compared to optimized IR CD/LD
- Hours of “on” time per dose at baseline and study end: 2.17 and 3.55 with RYTARY vs 2.24 and 2.38 with IR CD/LD
RYTARY has a safety profile similar to IR CD/LD
RYTARY stays with you longer than IR CD/LD
Each dose of RYTARY keeps levodopa levels steady for longer over a 12-hour period than other CD/LD medications. After delivering an initial peak of levodopa at about 1 hour, RYTARY continues to deliver levodopa for up to 4 to 5 hours.
Want to learn more about what makes RYTARY different?
Hear how movement disorder specialist Dr Drew Falconer explains the differences between RYTARY and IR CD/LD to his own patients.
time with RYTARY, I’m
able to do more than I ever
thought I could with my
Parkinson’s diagnosis.”
Individual results may vary.
Could RYTARY be right for you?
Sign up to receive a free information kit, and talk to your healthcare provider about your options.
SIGN UPCould RYTARY be right for you?
Find out if you’re eligible to save on RYTARY
BlinkRx offers financial assistance with automatically applied savings and co-pay support so people taking RYTARY can access and afford their medication.
